Pliant Therapeutics, Inc.
PLRX· Nasdaq
Released May 9, 2023, after the close
10-Q filed May 9, 2023, 39 days after period end · 0001746473-23-000031
| Metric | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 |
|---|---|---|---|---|
| Revenue | $1.33M | $1.25M | $2.17M | $28.94M |
| Net Income | -$37.55M | -$28.10M | -$22.86M | $11.03M |
| EPS Diluted |
Pliant Therapeutics, Inc. · CIK 1746473 · Engraved from SEC EDGAR
| -$0.67 |
| -$0.78 |
| -$0.64 |
| $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.